At the time of writing, Evolus Inc [EOLS] stock is trading at $10.79, up 6.73%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EOLS shares have gain 14.60% over the last week, with a monthly amount drifted -19.90%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Evolus Inc [NASDAQ: EOLS] stock has seen the most recent analyst activity on April 17, 2025, when BTIG Research initiated its Buy rating and assigned the stock a price target of $21. Previously, Barclays upgraded its rating to Overweight on January 29, 2024, and elevated its price target to $16. On June 23, 2022, Needham initiated with a Buy rating and assigned a price target of $18 on the stock. Barclays upgraded its rating to a Equal Weight and increased its price target to $10 on May 12, 2022. Truist upgraded its rating to a Buy but $11 remained the price target by the analyst firm on January 20, 2022. Mizuho upgraded its rating to Buy for this stock on May 06, 2021, but kept the price target unchanged to $15. In a note dated April 08, 2021, H.C. Wainwright reiterated an Buy rating on this stock and boosted its target price from $20 to $22.
For the past year, the stock price of Evolus Inc fluctuated between $8.67 and $17.82. Currently, Wall Street analysts expect the stock to reach $24 within the next 12 months. Evolus Inc [NASDAQ: EOLS] shares were valued at $10.79 at the most recent close of the market. An investor can expect a potential return of 122.43% based on the average EOLS price forecast.
Analyzing the EOLS fundamentals
According to Evolus Inc [NASDAQ:EOLS], the company’s sales were 266.27M for trailing twelve months, which represents an 29.42% jump. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -0.12%, Pretax Profit Margin comes in at -0.19%, and Net Profit Margin reading is -0.19%. To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -4.1 and Total Capital is -0.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of23.54.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.42 points at the first support level, and at 10.05 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.07, and for the 2nd resistance point, it is at 11.34.
Ratios To Look Out For
It is important to note that Evolus Inc [NASDAQ:EOLS] has a current ratio of 2.40. As well, the Quick Ratio is 2.21, while the Cash Ratio is 1.38. Considering the valuation of this stock, the price to sales ratio is 2.58, the price to book ratio is 124.08.
Transactions by insiders
Recent insider trading involved MOATAZEDI DAVID, that happened on Mar 27 ’25 when 6251.0 shares were sold., Avelar Rui completed a deal on Mar 18 ’25 to sell 27904.0 shares. Meanwhile, Chief Financial Officer Beaver Sandra sold 8996.0 shares on Mar 18 ’25.
